-
Lianluo Smart Limited Announces Pricing of Approximately $3.4 Million Offering
prnasia
February 29, 2020
Under the terms of the securities purchase agreement, the Company has agreed to sell 4.9 million Class A Common Shares.
-
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares
firstwordpharma
April 04, 2019
Goldman Sachs & Co. LLC and Citigroup are acting as joint lead book-running managers for the global offering. H.C. Wainwright & Co……
-
Ligand Pharma readies $650M convertible debt offering
biospectrumasia
May 18, 2018
In connection with the offering of the notes, Ligand expects to grant the initial purchasers a 13-day option to purchase up to an additional $100 million aggregate principal amount of the notes, solely to cover overallotments, if any.
-
Pulmatrix Announces Pricing Of $15.2 Million Underwritten Public Offering
biospace
March 30, 2018
Pulmatrix, Inc. ("Pulmatrix," the "Company," "we," "our" or "us") (NASDAQ: PULM) today announced the pricing of an underwritten public offering of an aggregate of 23,500,000 units.
-
QuintilesIMS Announces Offering of Senior Notes and Proposed Refinancing of Existing Indebtedness
IMS Health
February 23, 2017
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE: Q) today announced that its wholly owned subsidiary, Quintiles IMS Incorporated (the “Issuer”), intends to raise €850 million in gross proceeds through an offering of senior notes due 2025.